Figure1 (Ritonavir Fig1)
Ritonavir Tablet, Film Coated
Product Images NDC 65862-687
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ritonavir (NDC 65862-687). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Package Label Principal Display Panel (100 mg (30 Tablets Bottle))
Ritonavir Tablets USP, distributed by Aurohindo Pharma USA, Inc., are film-coated tablets containing 100 mg of ritonavir USP. The usual dosage information can be found in the package insert. These tablets should be swallowed whole with meals and not chewed, broken, or crushed. They should be stored at or below 30°C (86°F) and should not be exposed to high humidity outside of the original or USP equivalent container (75 mL) for longer than 7 days or at temperatures up to 50°C (122°F) for seven days. Pharmacists and patients should be aware of other medications that should not be taken with ritonavir tablets. These tablets come in a bottle with 30 tablets, and they should not be accepted if the seal over the bottle opening is broken or missing.*
Chemical Structure (Ritonavir Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
